Sweden’s Sobi to Buy CTI Biopharma for $1.7 Billion
(Bloomberg) -- Sweden's Orphan Biovitrum AB has agreed to buy US biotech CTI BioPharma Corp. , which is developing treatments for blood-related cancers, in a deal worth $1.7 billion.Most Read from BloombergShares of Sobi fell as much as…
